CoChat

Profibrotic Role for Interleukin-4 in Cardiac Remodeling and Dysfunction

Open access
Peng, Hongmei, Sarwar, Zeyd, Yang, Xiao-Ping, Peterson, Edward L., Xu, Jiang, Janic, Branislava, Rhaleb, Nadia, Carretero, Oscar A., Rhaleb, Nour-Eddine · 2015 · Hypertension
Cited by 111

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Elevated interleukin-4 (IL-4) levels are associated with cardiac fibrosis in hypertension and heart failure in both patients and experimental animals. We hypothesized that chronically elevated IL-4 induces cardiac fibrosis, resulting in a predisposition of the heart to angiotensin II–induced damage. Wild-type Balb/c (WT, high circulating IL-4) and IL-4–deficient Balb/c mice (IL-4 −/− ) were used. WT mice exhibited cardiac fibrosis (evidenced by an increase in expression of procollagen genes/interstitial collagen fraction), enlarged left ventricle chamber, and declined cardiac function associated with a greater number of mast cells and macrophages in the heart compared with IL-4 −/− . In contrast, IL-4 −/− mice had normal cardiac architecture/function while showing a 57.9% reduction in heart interstitial collagen compared with WT, despite elevated proinflammatory cytokines in heart tissue. In response to angiotensin II administration, IL-4 −/− had reduced interstitial myocardial fibrosis and were protected from developing dilated cardiomyopathy, which was seen in WT mice. This was associated with increased macrophage infiltration into the hearts of WT mice, despite a similar degree of hypertension and increased cardiac transforming growth factor-β1 in both groups. In vitro data demonstrated that IL-4 upregulates procollagen genes and stimulates collagen production in mouse cardiac fibroblasts. This process is mediated by signal transducer and activator of transcription 6 signaling pathway via IL-4 receptor alpha. This study not only establishes a causal relationship between IL-4 and cardiac fibrosis/dysfunction, but also reveals a critical role for IL-4 in angiotensin II–induced cardiac damage. IL-4 could serve as an additional target for the treatment of cardiac fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.115.05627

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 111

Metadata

Authors
Peng, H., Sarwar, Z., Yang, X.-P., Peterson, E. L., Xu, J., Janic, B., Rhaleb, N., Carretero, O. A., & Rhaleb, N.-E.
Venue
Hypertension
Published
2015-09
Volume
66
Issue
3
Pages
582-589
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W1934533055
Cited by
111
References
3
FWCI
4.91
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Profibrotic Role for Interleukin-4 in Cardiac Remodeling and Dysfunction. https://app.cochat.ai/papers/10.1161/hypertensionaha.115.05627
The paper
Peng, H., Sarwar, Z., Yang, X.-P., Peterson, E. L., Xu, J., Janic, B., Rhaleb, N., Carretero, O. A., & Rhaleb, N.-E. (2015). Profibrotic Role for Interleukin-4 in Cardiac Remodeling and Dysfunction. Hypertension. https://doi.org/10.1161/hypertensionaha.115.05627

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.